Research indexJournal article
Клиническая эффективность вакцинации конъюгированной пневмококковой вакциной пациентов с хронической бронхолегочной патологией в Городском пульмонологическом центре Челябинска
Игнатова, Родионова
Пульмонология26 Sep 2014
NobleIDark:/48914/w1/20260515/92E6B943DOI10.18093/0869-0189-2013-0-6-739-750
Клиническая эффективность вакцинации конъюгированной пневмококковой вакциной пациентов с хронической бронхолегочной патологией в Городском пульмонологическом центре Челябинска
Игнатова, Родионова · Пульмонология · 2014 · Subscription
NobleIDark:/48914/w1/20260515/92E6B943DOI10.18093/0869-0189-2013-0-6-739-750
The full text is at the publisher
You can read the abstract here, or open it at the publisher.
Abstract
Summary. Since November, 2012, patients with chronic lung disease, chronic heart failure (CHF) or a history of myocardial infarction have being actively vaccinated using 13-valent conjugated pneumococcal vaccine, in Chelyabinsk pulmonological centre. To December, 2013, 103 patients have been vaccinated. Safety of 13-valent conjugated pneumococcal vaccine was evaluated in all vaccinated patients. Efficacy was evaluated in 61 patients (21 with chronic obstructive pulmonary disease (COPD), 10 with bronchiectasis, 26 with COPD and asthma, and 4 with CHF. The vaccine efficacy was evaluated in a year after the vaccination. We found 4.8-fold reduction in exacerbation number in COPD patients, 4.1-fold reduction in bronchiectasis patients and 2.3-fold reduction in patients with COPD and asthma. Number of hospitalisations decreased in 9, 8 и 2.2 times, respectively; number of pneumonias decreased in 6; 4.1 and 2.3 times, respectively.